Pranita D. Tamma, MD, MHS
Areas of expertise: Pediatric infectious diseases
Locations: Main Building
About Pranita D. Tamma, MD, MHS
Titles
Attending Physician
Associate Professor
Awards and Honors
2024, National Oswald Avery Award for Early Achievement Awardee
2024, JHH Department of Pharmacy Interpersonal Practice Awardee
2022, National Gale and Ira Drukier Prize Awardee
2018, Pediatric Infectious Diseases Society Young Investigator Award
2018, Society for Healthcare Epidemiology of America Pediatric Investigator Award
2015, Faculty Teaching Award, awarded by Johns Hopkins Hospital Pediatric Residents
2013-2022 Baltimore Magazine “Top Pediatric Infectious Diseases Doctor”
2011, Fellow Teaching Award, awarded by Johns Hopkins School of Medicine Students
2011, Infectious Diseases Society of America Travel Award for Outstanding Abstract Submission
2010, KL2 Clinical Research Scholarship Awardee
2010-2015, National Institutes of Health Pediatric Loan Repayment Program Awardee
2009, Fellow Teaching Award, awarded by Johns Hopkins Hospital Residents
2007, Senior Resident Teaching Award, awarded by Johns Hopkins Hospital Interns
2004, summa cum laude upon graduation from 7-year combined college/medical school program
Leadership and Memberships
Advisory Committees, Review Groups/Study Sections
JHMI/Regional
2018-2020, Member, Johns Hopkins Medicine Pediatrics High Value Committee
2016-present, Member, The Johns Hopkins Health System Antimicrobial Stewardship Subcommittee
2016-2017, Member, The Johns Hopkins University Neonatology Chair Search Committee
2012-present, Member, The Johns Hopkins Hospital Antibiotic Subcommittee
2012-present, Member, The Johns Hopkins Health Systems Infectious Diseases Panel
2012-2016, Member, The Johns Hopkins Pediatric Intern Selection Committee
National
2022-present, Chair, Pediatric antimicrobial ReSISTance Treatment (PERSIST) Guidelines Workgroup
2018-present, Committee Member, American Academy of Pediatrics, Antimicrobial Resistance and Stewardship Subcommittee
2018-present, Committee Member, Infectious Diseases Society of America Intra-Abdominal Infection Guidelines
2022-2024, Abstract Reviewer, ID Week Abstracts
2022-2023, Chair, Clinical and Laboratory Standards Institute, Cefepime Breakpoint Working Group
2021-2023, Chair, Clinical Laboratory and Standards Institute, Piperacillin-Tazobactam Breakpoint Working Group
2020-2022, Committee Member, NIH Bacteriophage Taskforce
2019-2020, Committee Member, Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters M23 Working Group, Clinical and Laboratory Standards Institute
2018-2020, Committee Member, Society for Healthcare Epidemiology of America, Awards Committee
2018-2020, Committee Member, Centers for Disease Control and Prevention, Inpatient Antibiotic Prescribing: Reaching a National Goal for Reducing Inappropriate Use
2017, Committee Member, Clinical and Laboratory Standards Committee, Dalbavancin breakpoint working group
2017-2018, Committee Member, Clinical and Laboratory Standards Committee, Ceftaroline breakpoint working group
2014-2016, Committee Member, Society for Healthcare Epidemiology of America, Antimicrobial Stewardship Committee
2013-2019, Committee Member, Pediatric Infectious Diseases Society, Antimicrobial Stewardship Committee
International
2020-present, Advisor, Médecins Sans Frontières (Doctors Without Borders) Infectious Diseases Guidance
2020-present, Chair, Infectious Diseases Society of American Treatment of Antimicrobial Resistant Infections Guidelines
2018-present, Committee Member, Antibacterial Resistance Leadership Group, Gram-Negative Subcommittee
2018-present, Voting Member, Antimicrobial Susceptibility Testing Committee of the Clinical and Laboratory Standards Institute
2019-2020, Abstract Reviewer, European Society of Clinical Microbiology and Infectious Diseases International Conference
2014-2017, Advisor, Antimicrobial Susceptibility Testing Committee of the Clinical and Laboratory Standards Institute
2013-2015, Advisory Group, Global Antibiotic Resistance Partnership
Professional Societies
2009-present, Member, Society for Hospital Epidemiology of America
2008-present, Member, Pediatric Infectious Disease Society
2008-present, Member, Infectious Disease Society of America
Conference Organizer
National
2021-2024, Planning Committee Member, ID Week
2016-2020, Planning Committee Member, International Pediatric Antimicrobial Stewardship Meeting
International
2016, Planning Committee Member, International Symposium on Healthcare-Acquired Infections and Antimicrobial Stewardship, Cali, Colombia
2012, Planning Committee Member, Summer Institute of Advanced Epidemiology and Preventive Medicine, Tel Aviv, Israel
Session Chair
JHMI/Regional
National
5/14 Moderator, Clinical Challenges in Pediatric Antibiotic Management, Pediatric Academic Societies and Asian Society for Pediatr
4/15 Session Chair, Approaches to Decreasing the Spread of Drug-Resistant Organisms within the Acute Care Setting, The Society for Healthcare Epidemiology of America Conference, Orlando, FL
4/14 Session Chair, Diagnostic Challenges for Multidrug-Resistant Organisms, The Society for Healthcare Epidemiology of America, Denver, CO
Editorial and Academic Positions
2019-2020, Associate Editor, Journal of Pediatric Infectious Diseases Society
2019-present, Editor, Antimicrobial Agents and Chemotherapy
2016-2018, Editor, Practical Implementation of an Antibiotic Stewardship Program Textbook, Cambridge University Press
2014, Reviewer, Clinical Infectious Diseases Special Issue “Antimicrobial Stewardship: Patients over Process”
2013, Editor, Infectious Diseases Clinics of North America special issue on Antimicrobial Stewardship
Editorial Board Appointments
2017-2018, Editorial board, Antimicrobial Agents and Chemotherapy
2016-2018, Editorial board, Journal of Pediatric Infectious Diseases Society
Journal Peer Review Activities
2015-present, Journal of American Medical Association
2013-present, Clinical Infectious Diseases
2013-present, Antimicrobial Agents and Chemotherapy
2013-present, Infection Control & Hospital Epidemiology
2013-present, Journal of Antimicrobial Chemotherapy
2012-present, Journal of Pediatric Infectious Diseases Society
2012-present, Journal of American Medical Association Pediatrics
Education & training
Graduate Degree
MHS, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Medical Degree
BS/MD, State University of New York Downstate Medical School, New York, NY
Internship
Pediatrics, Johns Hopkins Hospital, Baltimore, MD
Residency
Resident, Pediatrics, Johns Hopkins Hospital, Baltimore, MD
Fellowship
Pediatric Infectious Diseases, Johns Hopkins Hospital, Baltimore, MD
Publications
Publications
2021
Anesi JA, Lautenbach E, Tamma PD, Thom K, Blumberg EA, Alby K, Bilker WB, Werzen A, Tomoleo P, Omorogbe J, Pineles MA, Han JH. Risk Factors for Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infection among Solid Organ Transplant Recipients. Clin Infect Dis. 2021;72(6):953-960. Assisted with study design, data collection, interpretation of results, and manuscript review.
Same RG, Amoah J, Hsu AJ, Hersh AL, Sklansky DJ, Cosgrove SE, Tamma PD. The Association of Antibiotic Duration with Successful Treatment of Community-Acquired Pneumonia in Children. J Pediatr Infect Dis Soc. 2021;10(3):267-273.
2020
Blanco N, Leekha S, Magder L, Jackson SS, Tamma PD, Lemkin D, Harris AD. Admission Laboratory Values Accurately Predict In-Hospital Mortality: a retrospective cohort study. J Gen Intern Med. 2020;35(3):719-723. Assisted with study design, interpretation of results, and manuscript review.
Kohut M, Keller SC, Linder J, Tamma PD, Cosgrove SE, Speck K, Ahn R, Dullabh P, Miller MA, Szymczak J. The Inconvincible Patient: How Clinicians Perceive Demand for Antibiotics in the Outpatient Setting. Fam Pract. 2020;37(2):276-282. Assisted with obtaining funding, study design, interpretation of results, and manuscript review.
Vock I, Aguilar Biltet L, Egli A, Tamma PD, Tschudin-Sutter S. Independent and external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales. Euro Surveill. 2020;25(26):1900317.
Klein E, Tseng KT, Hinson J, Goodman KE, Smith A, Toerper M, Amoah J, Tamma PD, Levin SR, Milstone AM. The Role of Healthcare Worker-Mediated Contact Networks in the Transmission of Vancomycin-Resistant Enterococci. Open Forum Infect Dis. 2020;7(3): ofaa056. Assisted with study design, interpretation of results, and manuscript review.
Amoah J, Stuart EA, Cosgrove SE, Harris AD, Han JH, Lautenbach E, *Tamma PD. Comparing Propensity Score Methods versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections. Clin Infect Dis. 2020;71(9):e497-e505.
Sharara SL, Amoah J, Pana ZD, Simner PJ, Cosgrove SE, *Tamma PD. Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by ESBL-producing Organisms? Clin Infect Dis. 2020;71(8):e331-e337.
Maliha GM, Nepps ME, *Tamma PD, Ashley ED, Szymczak JE, Kolesar E, Hamilton KW. Legal Implications of Antibiotic Stewardship. Infect Control Hosp Epidemiol. 2020;41(7):757-764. Assisted with manuscript drafting.
Keller SC, Tamma PD, Salinas A, Williams D, Cosgrove SE. Engaging Patients and Caregivers in a Transdisciplinary Effort to Improve Outpatient Parenteral Antimicrobial Therapy. Open Forum Infect Dis. 2020;7(6):ofaa188. Assisted with manuscript drafting.
Yee R, Breitwieser FP, Hao S, Opene BNA, Workman RE, Tamma PD, Dien-Bard J, Timp W, Simner PJ. Metagenomic next-generation sequencing of rectal swabs for the surveillance of antimicrobial-resistant organisms on the Illumina Miseq and Oxford MinION platforms. Eur J Clin Microbiol Infect Dis. 2020;40(10):95-102. Assisted with study design, isolate testing, interpretation of results, and manuscript review.
Morris CP, Bergman Y, Tekle T, Fissel J, Tamma PD, Simner PJ. Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-negative Bacilli: A Comparison of Disk Diffusion to Broth Microdilution. J Clin Microbiol. 2020;59(1):e01649-20. Assisted with study design, isolate testing, interpretation of results, and manuscript review.
Fox MT, Amoah J, Hsu AJ, Herzke CA, Gerber JS, *Tamma PD. The Association of Antibiotic Duration with Successful Treatment of Pyelonephritis in Children. JAMA Network Open. 2020;3(5):e203951.